BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 4801247)

  • 1. Letter: The effect of tyramine on the transport of 5-hydroxytryptamine in blood platelets.
    Genegke IK; Dalsgaard-Nielsen T
    Acta Pharmacol Toxicol (Copenh); 1973; 33(1):74-8. PubMed ID: 4801247
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of 4-methyl-alpha-ethyl-tyramine, 4, alpha-dimethyl-tyramine and tetrabenazine on the release and uptake of 5-hydroxytryptamine by human blood platelets in vitro.
    Campbell IC; Todrick
    Life Sci; 1976 May; 18(10):1091-7. PubMed ID: 933699
    [No Abstract]   [Full Text] [Related]  

  • 3. Release in vitro of 5-hydroxytryptamine from spindle cells of the domestic fowl.
    Sorimachi M; Kataoka K; Inouye A; Hori S
    Eur J Pharmacol; 1970 May; 10(2):243-8. PubMed ID: 4986567
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of antidepressant and antimanic drugs on amine uptake in man.
    Fann WE; Davis JM; Janowsky DS; Kaufmann JS; Cavanaugh JH; Oates JA
    J Nerv Ment Dis; 1974 May; 158(5):361-8. PubMed ID: 4596092
    [No Abstract]   [Full Text] [Related]  

  • 5. A simple superfusion technique for studying release of radiolabelled 5-hydroxytryptamine from blood platelets without interference of reuptake.
    Stoof JC; Mulder AH
    J Pharm Pharmacol; 1976 Apr; 28(4):323-4. PubMed ID: 6729
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of serotonin uptake inhibitor, Lilly 110140, on transport of serotonin in rat and human blood platelets.
    Horng JS; Wong DT
    Biochem Pharmacol; 1976 Apr; 25(7):865-7. PubMed ID: 938588
    [No Abstract]   [Full Text] [Related]  

  • 7. 5-hydroxytryptamine and adenine uptake by human blood platelets following the release reaction.
    Wesemann W; von Pusch I
    Thromb Res; 1981 Feb 15-Mar 1; 21(4-5):367-74. PubMed ID: 7268689
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of monoamine liberators on the metabolism of 5-hydroxytryptamine in blood platelets.
    Da Prada M; Bartholini G; Pletscher A
    Biochem Pharmacol; 1965 Dec; 14(12):1721-6. PubMed ID: 5880530
    [No Abstract]   [Full Text] [Related]  

  • 9. Mechanism of 5-hydroxytryptamine release induced by bacterial lipopolysaccharide from blood platelets. II. Comparison of morphological changes in platelets induced by various releasers.
    Kuruma I; Takagi H
    Jpn J Pharmacol; 1968 Mar; 18(1):68-79. PubMed ID: 4876761
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of histamine and 5-hydroxytryptamine uptake by trans- and cis-2-phenylcyclopropylamine in rabbit blood platelets.
    Tuomisto J; Walaszek EJ
    Med Biol; 1974 Aug; 52(4):255-9. PubMed ID: 4418158
    [No Abstract]   [Full Text] [Related]  

  • 11. Serotonin (5-hydroxytryptamine) release and uptake in platelets from healthy persons and migrainous patients in attack-free intervals.
    Dalsgaard-Nielsen T; Genefke IK
    Headache; 1974 Apr; 14(1):26-32. PubMed ID: 4832733
    [No Abstract]   [Full Text] [Related]  

  • 12. Depressed uptake of serotonin by platelets in hepatic encephalopathy.
    Wardle EN; Williams R
    Biochem Med; 1980 Oct; 24(2):223-7. PubMed ID: 7458927
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of drugs upon the uptake of 5-hydroxytryptamine and metaraminol by human platelets.
    Ahtee L; Saarnivaara L
    J Pharm Pharmacol; 1971 Jul; 23(7):495-501. PubMed ID: 4397447
    [No Abstract]   [Full Text] [Related]  

  • 14. Letter: Similarity between the effects of dimethyl and monomethyl tricyclic drugs on reserpine effects in the frog and 5-hydroxytryptamine uptake by human blood platelets.
    Oxenkrug GF
    J Pharm Pharmacol; 1973 Dec; 25(12):1013-5. PubMed ID: 4150289
    [No Abstract]   [Full Text] [Related]  

  • 15. Fluoxetine, a selective serotonin uptake inhibitor.
    Lemberger L; Rowe H; Carmichael R; Crabtree R; Horng JS; Bymaster F; Wong D
    Clin Pharmacol Ther; 1978 Apr; 23(4):421-9. PubMed ID: 630789
    [No Abstract]   [Full Text] [Related]  

  • 16. Uptake of the neuron-blocking agent meta-iodobenzylguanidine and serotonin by human platelets and neuro-adrenergic tumour cells.
    Rutgers M; Tytgat GA; Verwijs-Janssen M; Buitenhuis C; Voƻte PA; Smets LA
    Int J Cancer; 1993 May; 54(2):290-5. PubMed ID: 8486431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of ergotamine and dihydroergotamine on uptake of 5-hydroxytryptamine in blood platelets.
    Lingjaerde O
    Eur J Pharmacol; 1970; 13(1):76-82. PubMed ID: 5496931
    [No Abstract]   [Full Text] [Related]  

  • 18. [Release of serotonin and histamine from thrombocytes by aliphatic and aromatic amines].
    May B; Menkens I; Westermann E
    Naunyn Schmiedebergs Arch Pharmakol; 1969; 265(1):24-48. PubMed ID: 4104325
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of 5,6-dihydroxytryptamine on uptake, storage and metabolism of 5-hydroxytryptamine by blood platelets.
    Da Prada M; O'Brien RA; Tranzer JP; Pletscher A
    J Pharmacol Exp Ther; 1973 Aug; 186(2):213-9. PubMed ID: 4719776
    [No Abstract]   [Full Text] [Related]  

  • 20. Different localization of reserpine and tyramine within the 5-hydroxytryptamine organelles of blood platelets.
    Da Prada M; Pletscher A
    Experientia; 1969 Sep; 25(9):923-4. PubMed ID: 5371413
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.